-SSS/Lipiodol: Development of a Potential Treatment for HCC from Bench to Bedside
Figure 14
Scintigraphy (a) showing intense hyperfixation (in black) in 4 tumour foci, CT scan (b) showing intense Lipiodol retention (in white) in the nodules and fusion image (c) of scintigraphy and CT scan; 71-year-old male, 1 h after injection of 1.85 GBq of 188Re-SSS/Lipiodol. Transverse, sagittal, and coronal views.